Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taff Jones

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Vaccine|August 19, 2004
Protollin: a novel adjuvant for intranasal vaccinesTaff Jones, Sonya Cyr, Francine Allard, et al.
Vaccine|July 21, 2007
Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in miceMary C Hu, Taff Jones, Richard T Kenney, et al.
Vaccine|June 15, 2007
Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathologySonya L Cyr, Taff Jones, Ioana Stoica-Popescu, et al.
Plos One|November 10, 2010
Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trialsRaburn M Mallory, Elissa Malkin, Christopher S Ambrose, et al.
Vaccine|August 19, 2003
A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunityTaff Jones, Francine Allard, Sonya L Cyr, et al.
Vaccine|October 26, 2005
Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infectionTaff Jones, Jeffrey J Adamovicz, Sonya L Cyr, et al.
Vaccine|November 24, 2005
Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adultsJoanne M Langley, Scott A Halperin, Shelly McNeil, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Vaccine|August 19, 2004
Protollin: a novel adjuvant for intranasal vaccinesTaff Jones, Sonya Cyr, Francine Allard, et al.
Vaccine|July 21, 2007
Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in miceMary C Hu, Taff Jones, Richard T Kenney, et al.
Vaccine|June 15, 2007
Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathologySonya L Cyr, Taff Jones, Ioana Stoica-Popescu, et al.
Plos One|November 10, 2010
Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trialsRaburn M Mallory, Elissa Malkin, Christopher S Ambrose, et al.
Vaccine|August 19, 2003
A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunityTaff Jones, Francine Allard, Sonya L Cyr, et al.
Vaccine|October 26, 2005
Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infectionTaff Jones, Jeffrey J Adamovicz, Sonya L Cyr, et al.
Vaccine|November 24, 2005
Safety and immunogenicity of a Proteosome -trivalent inactivated influenza vaccine, given nasally to healthy adultsJoanne M Langley, Scott A Halperin, Shelly McNeil, et al.
Pageof 3